Literature DB >> 28585474

Family experience with osteogenesis imperfecta type 1: the most distressing situations.

Margarida Custódio Dos Santos1,2, Ana Filipa Pires1, Kelly Soares1, Luísa Barros1.   

Abstract

BACKGROUND: Osteogenesis imperfecta (OI) is a rare genetic disorder characterized by decreased bone mass and increased bone fragility. Despite increasing research on the biomedical aspects of the disease, only a few studies focus on the psychosocial implications of living with OI. This study aimed to explore the situations that are perceived by OI type-1 children, their parents and siblings, as being the most distressing and stressful in their experience with the disease.
METHODS: Seven families of children diagnosed with OI type 1 for longer than four years participated. An in-depth semistructured interview with open-ended questions was used to separately collect each participant's (mother, father, patient and sibling) subjective report of their experience. Interviews were audiotaped and a qualitative discourse analysis was performed.
RESULTS: Pain and fractures, hospitalization, home recovery, back to school and time of diagnosis emerged as the most challenging situations. Time of diagnosis was only mentioned by parents. Some commonalities but also relevant differences in the subjective experience of the same situations, depending on the family role, were found.
CONCLUSIONS: Our results reinforce the assumption that OI is a family matter and point to the importance of providing comprehensive and family-centered health and educational services tailored to each family member and to the different situations faced by these families. Implications for rehabilitation Osteogenesis imperfecta is a chronic rare disease that impacts severely the patient's life and the life of all family members. The most distressing situations are related to fractures and pain, hospitalization, recovery from fractures while being at home and preparing for school reentry. All family members participate in the rehabilitation process, each one accomplishing different tasks. Rehabilitation should include educational and psychological intervention to enhance family strengths and support all family members. Tailored and effective communication from health providers may play a critical role in the rehabilitation process.

Entities:  

Keywords:  Osteogenesis imperfecta; families; rare disease; stressful situation; subjective experience

Mesh:

Year:  2017        PMID: 28585474     DOI: 10.1080/09638288.2017.1334236

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  5 in total

1.  Specific nursing improves postoperative urine control function and the self-efficacy of patients undergoing radical prostatectomies.

Authors:  Jiangliang Jiang; Liting Du; Xuhua Wang; Shuiying Huang; Wenhao Hu; Libo Zhou; Xiaoxu Liu
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

2.  Stakeholder views and attitudes towards prenatal and postnatal transplantation of fetal mesenchymal stem cells to treat Osteogenesis Imperfecta.

Authors:  Melissa Hill; Celine Lewis; Megan Riddington; Belinda Crowe; Catherine DeVile; Anna L David; Oliver Semler; Magnus Westgren; Cecilia Götherström; Lyn S Chitty
Journal:  Eur J Hum Genet       Date:  2019-03-27       Impact factor: 4.246

3.  The Caregiving Experiences of Fathers and Mothers of Children With Rare Diseases in Italy: Challenges and Social Support Perceptions.

Authors:  Paola Cardinali; Laura Migliorini; Nadia Rania
Journal:  Front Psychol       Date:  2019-08-05

4.  A Baseline Measurement of Quality of Life in 322 Adults With Osteogenesis Imperfecta.

Authors:  Koert Gooijer; Arjan G J Harsevoort; Fleur S van Dijk; Hendrikje Rik Withaar; Guus J M Janus; Anton A M Franken
Journal:  JBMR Plus       Date:  2020-11-07

5.  Providing high-quality care remotely to patients with rare bone diseases during COVID-19 pandemic.

Authors:  E Brizola; G Adami; G I Baroncelli; M F Bedeschi; P Berardi; S Boero; M L Brandi; L Casareto; E Castagnola; P Fraschini; D Gatti; S Giannini; M V Gonfiantini; V Landoni; A Magrelli; G Mantovani; M B Michelis; L A Nasto; L Panzeri; E Pianigiani; A Scopinaro; L Trespidi; A Vianello; G Zampino; L Sangiorgi
Journal:  Orphanet J Rare Dis       Date:  2020-08-31       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.